Matinas BioPharma Reports Second Quarter 2024 Financial Results and Provides a Business Update
PremiumPress ReleasesMatinas BioPharma Reports Second Quarter 2024 Financial Results and Provides a Business Update
1M ago
Matinas BioPharma to Webcast Conference Call to Discuss Second Quarter 2024 Financial Results and Provide a Business Update on August 14, 2024
Premium
Press Releases
Matinas BioPharma to Webcast Conference Call to Discuss Second Quarter 2024 Financial Results and Provide a Business Update on August 14, 2024
1M ago
Is MTNB a Buy, Before Earnings?
Premium
Pre-Earnings
Is MTNB a Buy, Before Earnings?
2M ago
New In Vitro Data Showing Matinas BioPharma’s LNC Platform Delivering Small Oligonucleotides Presented at TIDES USA 2024
PremiumPress ReleasesNew In Vitro Data Showing Matinas BioPharma’s LNC Platform Delivering Small Oligonucleotides Presented at TIDES USA 2024
4M ago
Matinas BioPharma Reports First Quarter 2024 Financial Results and Provides a Business Update
Premium
Press Releases
Matinas BioPharma Reports First Quarter 2024 Financial Results and Provides a Business Update
4M ago
Matinas BioPharma to Webcast Conference Call to Discuss First Quarter 2024 Financial Results and Provide a Business Update on May 9, 2024
Premium
Press Releases
Matinas BioPharma to Webcast Conference Call to Discuss First Quarter 2024 Financial Results and Provide a Business Update on May 9, 2024
5M ago
Matinas BioPharma Prices $10 Million Registered Direct Offering
PremiumPress ReleasesMatinas BioPharma Prices $10 Million Registered Direct Offering
6M ago
Matinas BioPharma Updates Presentation for Investor Outreach
Premium
Company Announcements
Matinas BioPharma Updates Presentation for Investor Outreach
6M ago
Matinas BioPharma Reports 2023 Financial Results and Provides a Business Update
Premium
Press Releases
Matinas BioPharma Reports 2023 Financial Results and Provides a Business Update
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100